Tesla, Inc. TSLA is preparing to launch its smart driving assistance feature in China once it secures regulatory approval. The decision followed concerns over a temporary pause in a limited-time ...

Lead asset DNL310 shows strong biomarker data for Hunter syndrome, with plans for a BLA submission and accelerated approval by Q2 ... for it (other than from Seeking Alpha). I have no business ...

Former President Donald Trump has tied his highest approval rating from his first term, reaching 47% according to an NBC poll. Despite the uptick in approval, other polls, such as Reuters/Ipsos ...

If planning and zoning approves the rezoning application, it will still have to get the county commission's approval. If planning and zoning denies the group, then Hope City Refuge stated it will ...

Bonnis scuttled his previous plan for the site, which had been in various approval stages going back to around 2017, last April. It had proposed a 17-storey commercial building that would rise up ...

A Mumbai-based CEO, Vinod Chendhil, sparked a hiring debate after rejecting a senior candidate who requested that her husband meet the company leadership before she accepted the job offer. Chendhil ...

President Trump's approval rating hovers around 47% according to various polls. Trump's approval rating remains largely partisan, with a significant gap between Democrats and Republicans.

Immunovant has decided not to seek regulatory approval for its myasthenia gravis (MG) therapy, batoclimab, despite the Phase III study achieving its primary endpoint of reducing disease symptoms.

Immunovant will not seek approval for batoclimab in MG or CIDP but plans registrational studies for IMVT-1402 in both conditions. Feel unsure about the market’s next move? Copy trade alerts from ...

Immunovant does not intend to seek regulatory approval for batoclimab in MG or CIDP and is focused on leveraging data and learnings from the batoclimab studies to accelerate programs with IMVT-1402.

The national NBC News poll reveals Trump's approval rating at 47%, his highest yet. The poll also shows that more registered voters now feel the country is heading in the right direction than at ...

The biotech plans to make a final decision on whether to seek approval for its first-generation FcRn inhibitor in the indication after seeing phase 3 data. Investors reacted negatively to the news ...